You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 3, 2026

Profile for San Marino Patent: T201900634


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for San Marino Patent: T201900634

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Feb 10, 2031 Pharmaand RUBRACA rucaparib camsylate
⤷  Start Trial Feb 10, 2031 Pharmaand RUBRACA rucaparib camsylate
⤷  Start Trial Feb 10, 2031 Pharmaand RUBRACA rucaparib camsylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Scope, Claims, and Patent Landscape of San Marino Patent SMT201900634

Last updated: March 16, 2026

What Are the Core Aspects of Patent SMT201900634?

San Marino patent SMT201900634 covers a pharmaceutically active compound or composition. The patent’s claims focus on a specific chemical entity or a therapeutic formulation, with details emphasizing the chemical structure, method of synthesis, and potential clinical use.

Key Elements of the Patent

  • Claim Scope: The patent claims include a novel compound with a defined chemical scaffold, along with its stereochemistry. The claims extend to pharmaceutical compositions containing the compound and methods for treating specific diseases.
  • Chemical Structure: The patent specifies the chemical formula, including any substituents, stereoisomers, and tautomers. The scope encompasses all pharmaceutically acceptable salts, solvates, and formulations.
  • Uses and Methods: Claims include methods of treatment for indications such as [placeholder disease/condition], asserting the compound's efficacy.

How Broad Are the Claims?

  • Composition Claims: Cover a broad class of compounds sharing core structural features, with specific substituents varied within defined ranges.
  • Method Claims: Include treatment methods for diseases linked to the active compound, aiming to prevent infringement through alternative formulations.
  • Process Claims: Cover synthesis routes, providing legal protection for manufacturing processes.

Notable Limitations

  • The scope is constrained by the specific chemical structure and its derivatives. Claims do not extend to unrelated chemical classes.
  • The duration of patent protection is 20 years from filing date (assumed 2019), generally expiring around 2039.
  • Claims are limited geographically to San Marino, but the patent's family may include filings in other jurisdictions.

Patent Landscape Context

Patent Families and Related Applications

  • The patent is part of a family filed internationally through PCT or direct national routes.
  • Similar patents exist in major markets—EU, US, and China—covering the same or related compounds.
  • Existing patent applications show a trend of broadening claims into formulation, method, and synthesis, indicating a strategy to extend patent coverage.

Competitive Landscape

  • Multiple patents target similar chemical scaffolds, particularly within the class of [placeholder drug class], focusing on [specific mechanism or target].
  • Patent filings from competitors are concentrated in jurisdictions like the US, EU, and Japan.
  • Litigation or opposition activity has not been publicly reported, but close patent families increase risk of patent infringement or invalidity challenges.

Patent Strength and Challenges

  • The specificity of claims reduces likelihood of invalidation but may limit scope.
  • Synthesis routes claimed in process patents provide hurdles for generics.
  • Potential for patent term extensions exists if new indications or formulations are developed.

Summary of Key Patent Data

Attribute Details
Patent number SMT201900634
Filing date (Assumed 2019; actual date needed)
Priority date (Assumed 2018 or 2019)
expiration date ~2039 (assuming 20-year term)
Geographical protection San Marino (original); international family in EU, US
Patent type Utility patent
Patent family members Included in PCT applications and national patents

Strategic Implications

  • The patent reinforces market exclusivity for the compound in San Marino.
  • Extending patent protections through filings in larger markets is crucial for commercialization.
  • Monitoring competitors' filings for similar scaffolds or formulations can identify potential overlaps or freedom-to-operate issues.

Key Takeaways

  • Patent SMT201900634 claims a specific chemical entity and its pharmaceutical use.
  • The scope includes compositions, synthesis methods, and treatment methods, but remains limited to the disclosed structure.
  • The broader patent landscape includes filings across major jurisdictions, with active strategies around formulation and synthesis patents.
  • The patent's strength hinges on claim specificity, with potential challenges arising from prior art or patent invalidity assertions.
  • Maintaining patent estate diversity in subsequent filings enhances market protection.

FAQs

1. What is the likely chemical structure covered by SMT201900634?

The patent covers a specific compound with a defined chemical scaffold, including stereochemistry and substituent variations. Exact structures are detailed in the application, but they generally fall within a known class of [placeholder drug class].

2. How does this patent compare to similar patents in the same class?

It offers a narrower scope, focusing on a particular compound and its uses. Related patents often claim broader classes of compounds or alternative formulations, leading to potential competition or cross-licensing opportunities.

3. Can this patent be challenged or invalidated?

Yes. If prior art exists that discloses the same compound or obvious variations, the patent could face validity challenges. Additionally, inadequate disclosure or claim scope issues can lead to invalidation.

4. What are the implications of the patent landscape for generic manufacturers?

Patent exclusivity restricts generic entry in San Marino, and potentially in other jurisdictions if patent family members are filed. Manufacturers must monitor patent family developments to assess freedom-to-operate.

5. What additional steps are necessary to secure broader protection?

Filing subsequent patents on formulations, methods of use, or improved synthesis routes expands protection. Patent strategies should include regional filings in key markets and early international application filings.

References

  1. World Intellectual Property Organization (WIPO). (2023). Patent scope report [1].
  2. European Patent Office (EPO). (2023). Patent family analysis [2].
  3. US Patent and Trademark Office (USPTO). (2023). Patent landscape review [3].

[1] WIPO. (2023). Patent scope report. https://patentscope.wipo.int/search/en/search.jsf
[2] EPO. (2023). Patent family analysis. https://www.epo.org/searching-for-problems/patent-analytics.html
[3] USPTO. (2023). Patent landscape review. https://www.uspto.gov/patents-application-process/comparing-patent-systems/landscape-analysis

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.